Perioperative Management of Buprenorphine Therapy & Acute Pain

January 26, 2021

Live Virtual Session – 3pm and again at 6pm, Bangor, ME

            Audience:       Accredited for Pharmacists and Technicians

                                    Other interested health care professionals welcome

            Credits:          1 Contact Hour of knowledge-based

                                    1.0 CEUs will be awarded under the provider

            Presenter(s):  Henry Sherman, PharmD,

                                    PGY-1 Pharmacy Practice Resident, Northern Light Eastern Maine Medical Center

No charge for CE

Learning Objectives for Pharmacists:

0837-9999-21-003-L01-P

After attending this program, participants will be able to:

1. Recognize the pharmacologic activity of buprenorphine and full opioid agonists
2. Review the implications of continuing buprenorphine perioperatively versus discontinuing buprenorphine
3. Describe available evidence for continuation of buprenorphine through a perioperative period
4. Discuss strategies for acute pain management on buprenorphine
5. Arrange the general principles of pain management in MAT to a patient case

Learning Objectives for Technicians:

0837-9999-21-002-L01-T

1. Define opioid debt and opiophobia
2. Describe how opioid debt and opiophobia impact pain management in patients with medication assisted treatment (MAT)
3. Review the duration of action for analgesia versus withdrawal suppression for MAT

Requirements for Receiving CE Credit:

• Successful completion of post-presentation questions
• Participation at live program
• Complete program online evaluation form
• NABP #